Tower Research Capital LLC (TRC) - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$7,281
-77.8%
2,485
-78.3%
0.00%
-100.0%
Q2 2023$32,736
+233728.6%
11,446
+147.5%
0.00%
Q1 2023$14
+55.6%
4,625
+1.8%
0.00%
Q4 2022$9
-99.9%
4,545
+14.0%
0.00%
Q3 2022$13,000
-38.1%
3,988
-40.4%
0.00%
Q2 2022$21,000
-30.0%
6,695
+60.2%
0.00%
Q1 2022$30,000
-9.1%
4,179
-8.4%
0.00%
-100.0%
Q4 2021$33,0004,5600.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders